
CON
USDConcentra Group Holdings Parent Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$21.700
Максимум
$21.980
Минимум
$21.395
Объем
0.06M
Фундаментальные показатели компании
Рыночная капитализация
2.8B
Отрасль
Medical Care Facilities
Страна
United States
Статистические данные торговли
Средний объем
0.80M
Биржа
NYQ
Валюта
USD
52-недельный диапазон
Отчет об анализе ИИ
Последнее обновление: 2 мая 2025 г.CON (Concentra Group Holdings Parent Inc. Common Stock): Analyzing Recent Moves & What Might Come Next
Stock Symbol: CON Generate Date: 2025-05-02 16:21:32
Alright, let's break down what's been happening with Concentra stock lately and what the tea leaves might be suggesting. We'll look at the recent news, how the price has been acting, and what some automated predictions are saying.
Recent News Buzz
So, what's the latest chatter around Concentra? There are a few key things that popped up recently:
- Earnings Coming Up: The big news is that Concentra plans to announce their first-quarter results for 2025 on May 7th, right after the market closes. This is a pretty standard announcement, but it's a major event for any stock. Investors will be watching closely to see how the company performed financially. It's a moment of anticipation – results could be good, bad, or somewhere in between, and that will definitely move the stock price.
- Analyst Thumbs Up: Back in March, a JP Morgan analyst named Lisa Gill gave Concentra a positive rating ("Overweight") and even nudged her price target up a dollar, from $29 to $30. This is generally seen as a good sign. When a respected analyst thinks a stock is worth more than they previously did, it can give other investors confidence.
- Expanding the Footprint: Also in March, Concentra announced they opened a new medical center in Waukegan, Illinois. Since Concentra is all about occupational medicine (helping people with work-related health stuff), opening new locations means they're growing their business. That's usually a positive development for a company's long-term prospects.
Putting the news together, the vibe is somewhat mixed but leans positive overall. You've got solid business growth news (expansion) and a vote of confidence from an analyst (price target raise). The upcoming earnings report is the big unknown, creating a bit of a wait-and-see situation.
Price Check: What the Chart Shows
Looking at the stock's price over the last 30 days or so, it's been a bit of a rollercoaster. Back in early March, the price was hanging around the $22-$23 mark. Then, it took a noticeable dip, falling below $21 by mid-March and even touching the $19 range briefly in early April.
However, since that dip in early April, the stock has shown signs of bouncing back. It's been gradually climbing, moving from the $19-$20 area back up towards the $21-$22 range in the latter half of April and into early May. The last recorded price point shows it around $21.61.
Comparing the current price to the recent trend, it seems to be recovering from that earlier dip and is now sitting near the upper end of its range over the last few weeks, though still below where it was in early March.
What about the AI's crystal ball? The prediction model suggests minimal movement today (0.00%), a small bump tomorrow (+0.56%), and then a more significant jump the day after (+3.63%). This forecast points towards a potential upward move in the very near term.
Outlook & Ideas: What Might This Mean?
Based on the news, the recent price action, and the AI's short-term prediction, the situation for CON looks cautiously optimistic in the immediate future, but with a big asterisk for the upcoming earnings report.
- The Lean: The combination of positive news (expansion, analyst upgrade), a recent price recovery, and an AI predicting upward movement suggests the near-term leaning might favor those looking to potentially buy or hold. It doesn't scream "sell" right now, but the earnings report is a major wildcard that could change things fast.
- Potential Entry Consideration: If you were considering getting into this stock, the current price area, around $21.50-$21.60, might be a point to look at. The AI prediction data even flagged entry points around $21.54 and $21.64. This level seems to be acting as a recent point of interest after the stock's recovery. However, remember the earnings report is just days away, which adds risk.
- Potential Exit/Stop-Loss Consideration: If you're already in or decide to get in, thinking about where you might take profits or cut losses is smart. The AI data suggested a potential take-profit level around $21.96. This is close to recent highs and aligns with the idea of a short-term upward move. For managing risk, a potential stop-loss level mentioned in the data is $19.38. Placing a stop-loss below recent significant lows (like that dip in early April) is a common strategy to limit potential losses if the stock turns south unexpectedly, especially after the earnings announcement.
Company Context
Just a quick reminder about Concentra: they are a healthcare company focused on occupational medicine. This means their business is tied to employers needing health services for their workers (like injury care, physicals, drug testing). So, news about expanding locations or trends in the job market and workplace safety are particularly relevant to how this company performs. They are a sizable company with over 8,700 employees and a market cap around $2.77 billion.
Remember, this analysis is based only on the data provided and is just one perspective. Stock markets can be unpredictable, and prices can go down as well as up.
Disclaimer: This report is for informational and analytical purposes only and should not be considered financial advice. It is based on the provided data and interpretations thereof. Investing in stocks involves risk, and you could lose money. Always conduct your own thorough research or consult with a qualified financial advisor before making any investment decisions.
Связанные новости
Concentra® to Announce First Quarter 2025 Results on Wednesday, May 7, 2025
Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) will release the financial results for its first quarter ended March 31, 2025, on Wednesday, May 7, 2025, after the market closes. Concentra will
JP Morgan Maintains Overweight on Concentra Group Holdings, Raises Price Target to $30
JP Morgan analyst Lisa Gill maintains Concentra Group Holdings with a Overweight and raises the price target from $29 to $30.
Concentra Expands to Waukegan, Illinois
Concentra®, the nation's leader in occupational medicine, today announced the opening of a new medical center in Waukegan, Illinois. The medical center, Concentra Waukegan, is conveniently located at 3043A
Прогноз ИИBeta
Рекомендация ИИ
Обновлено в: 2 мая 2025 г., 22:28
62.9% Уверенность
Риск и торговля
Точка входа
$21.54
Взять прибыль
$21.96
Остановить убытки
$19.38
Ключевые факторы
Связанные акции

TARS
Tarsus Pharmaceuticals Inc.

BGX
Blackstone Long Short Credit Income Fund Common Shares

WBD
Warner Bros. Discovery Inc. Series A

ANL
Adlai Nortye Ltd. American Depositary Shares

COP
ConocoPhillips
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.